BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 16483705)

  • 1. The importance of GRAS to the functional food and nutraceutical industries.
    Burdock GA; Carabin IG; Griffiths JC
    Toxicology; 2006 Apr; 221(1):17-27. PubMed ID: 16483705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of cGMP compliance on consumer confidence in dietary supplement products.
    Crowley R; FitzGerald LH
    Toxicology; 2006 Apr; 221(1):9-16. PubMed ID: 16469425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA perspectives on health claims for food labels.
    Rowlands JC; Hoadley JE
    Toxicology; 2006 Apr; 221(1):35-43. PubMed ID: 16480811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
    Gibson JE; Taylor DA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):939-44. PubMed ID: 15833895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary supplements and lessons to be learned from GRAS.
    Burdock GA
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):68-76. PubMed ID: 10715226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer.
    McNamara SH
    Food Drug Law J; 1999; 54(1):35-42. PubMed ID: 11758558
    [No Abstract]   [Full Text] [Related]  

  • 10. How the US Food and Drug Administration evaluates the scientific evidence for health claims.
    Ellwood KC; Trumbo PR; Kavanaugh CJ
    Nutr Rev; 2010 Feb; 68(2):114-21. PubMed ID: 20137056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
    Saldanha LG
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
    Seamon MJ; Clauson KA
    J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the dietary supplement health and education act on consumer beliefs about the safety and effectiveness of dietary supplements.
    Dodge T; Litt D; Kaufman A
    J Health Commun; 2011 Mar; 16(3):230-44. PubMed ID: 21120738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary supplement adverse event reports: review and analysis.
    Talati AR; Gurnani AK
    Food Drug Law J; 2009; 64(3):503-13. PubMed ID: 19999641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New dietary ingredient notifications: a comprehensive review and strategies for avoiding FDA objections.
    Talati AR
    Food Drug Law J; 2007; 62(2):387-98. PubMed ID: 17632968
    [No Abstract]   [Full Text] [Related]  

  • 16. Dietary supplement labeling and advertising claims: are clinical studies on the full product required?
    Villafranco JE; Bond K
    Food Drug Law J; 2009; 64(1):43-67. PubMed ID: 19998572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA hearing highlights opposition to dietary supplement practices; written comments due August 20. Food and Drug Administration.
    James JS
    AIDS Treat News; 1999 Aug; (No 324):3-4. PubMed ID: 11366575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health foods and foods with health claims in Japan.
    Ohama H; Ikeda H; Moriyama H
    Toxicology; 2006 Apr; 221(1):95-111. PubMed ID: 16488527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Legislation relating to nutraceuticals in the European Union with a particular focus on botanical-sourced products.
    Gulati OP; Berry Ottaway P
    Toxicology; 2006 Apr; 221(1):75-87. PubMed ID: 16487647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.